Legro Richard S, Stetter Christy M, Kunselman Allen R, Geisler William M, Dodson William C, Estes Stephanie J
Department of Obstetrics and Gynecology, Penn State College of Medicine, Hershey Pennsylvania.
Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.
F S Rep. 2022 Nov 15;4(1):121-126. doi: 10.1016/j.xfre.2022.11.005. eCollection 2023 Mar.
To determine the feasibility, safety, and outcomes of an oil-based, iodinated contrast using office-based, ultrasound-imaged hysterosalpingography in women with infertility.
Randomized Controlled Double Blind Clinical Trial.
Academic health center.
Tubal flushing with oil-based contrast medium (Lipiodol UF) versus saline.
Ongoing pregnancy rate, pain, quality of life, and thyroid function.
Forty-eight patients (24 in each group) were analyzed. The groups were well-matched at baseline. Ongoing pregnancy was noted in 17% (4/24) of the oil-contrast group versus 37% (9/24) in the saline group. Saline group patients more frequently initiated infertility therapy in the six-month follow-up period (saline, 67% vs. oil, 33%), and no serious adverse events in either group. There were no differences in pain from the procedure between groups. There were no differences in thyroid function tests postprocedure between groups, but within the oil-contrast group, there was a slight increase in thyroid-stimulating hormone (post vs. preratio of geometric means: 1.18; 95% confidence interval [CI], 1.02-1.38) and decrease in Free T4 (postdifference vs. predifference in means: 0.08 ng/dL; 95% CI, -0.14 to -0.01). Immediately after the test, the physicians correctly guessed 79% of oil and 71% of saline randomization assignments, whereas patients correctly guessed 63% of oil and 38% of saline.
This pilot study demonstrates the safety and feasibility of giving an oil-based contrast medium during ultrasound-imaged hysterosalpingography. Pregnancies were seen after oil-based administration, and this contrast is associated with minor thyroid function impairment.
确定在不孕症女性中使用油基碘化造影剂,通过门诊超声子宫输卵管造影检查的可行性、安全性及结果。
随机对照双盲临床试验。
学术健康中心。
使用油基造影剂(超液化碘油)与生理盐水进行输卵管冲洗。
持续妊娠率、疼痛、生活质量及甲状腺功能。
分析了48例患者(每组24例)。两组在基线时匹配良好。油造影剂组持续妊娠率为17%(4/24),生理盐水组为37%(9/24)。在六个月的随访期内,生理盐水组患者更频繁地开始不孕症治疗(生理盐水组67%,油造影剂组33%),两组均未发生严重不良事件。两组之间手术引起的疼痛无差异。术后两组甲状腺功能测试无差异,但在油造影剂组中,促甲状腺激素略有升高(术后与术前几何均数之比:1.18;95%置信区间[CI],1.02 - 1.38),游离T4降低(术后与术前均值之差:0.08 ng/dL;95%CI, - 0.14至 - 0.01)。检查后立即进行判断,医生正确猜出79%的油造影剂随机分组和71%的生理盐水随机分组,而患者正确猜出63%的油造影剂分组和38%的生理盐水分组。
这项初步研究证明了在超声子宫输卵管造影检查期间给予油基造影剂的安全性和可行性。油基造影剂给药后出现了妊娠情况,且这种造影剂与轻微的甲状腺功能损害有关。